相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alanine dehydrogenase and its applications - A review
Ushmaben Chandrakantbhai Dave et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2019)
Diastereomers of a mono-substituted phosphoryl guanidine trideoxyribonucleotide: Isolation and properties
Alexander A. Lomzov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Neutral and Negatively Charged Phosphate Modifications Altering Thermal Stability, Kinetics of Formation and Monovalent Ion Dependence of DNA G-Quadruplexes
Yongdong Su et al.
CHEMISTRY-AN ASIAN JOURNAL (2019)
Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties
S. K. Miroshnichenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
Xiulong Shen et al.
NUCLEIC ACIDS RESEARCH (2018)
Analysis of new charge-neutral DNA/RNA analogues phosphoryl guanidine oligonucleotides (PGO) by gel electrophoresis
Alesya Fokina et al.
ANALYTICAL BIOCHEMISTRY (2018)
Advances in the delivery of antisense oligonucleotides for combating bacterial infectious diseases'
Xiao-Yan Xue et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Opening Pandora's Box: Mechanisms of Mycobacterium tuberculosis Resuscitation
Ashley V. Veatch et al.
TRENDS IN MICROBIOLOGY (2018)
Advances in therapeutic bacterial antisense biotechnology
John P. Hegarty et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
Delivery of therapeutic RNA-cleaving oligodeoxyribonucleotides (deoxyribozymes): from cell culture studies to clinical trials
Alesya A. Fokina et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
FDA-Approved Oligonucleotide Therapies in 2017
Cy A. Stein et al.
MOLECULAR THERAPY (2017)
Overcoming cellular barriers for RNA therapeutics
Steven F. Dowdy
NATURE BIOTECHNOLOGY (2017)
New oligodeoxynucleotide derivatives containing N-(methanesulfonyl)-phosphoramidate (mesyl phosphoramidate) internucleotide group
B. P. Chelobanov et al.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY (2017)
A common base method for analysis of qPCR data and the application of simple blocking in qPCR experiments
Michael T. Ganger et al.
BMC BIOINFORMATICS (2017)
New drugs for the treatment of Mycobacterium tuberculosis infection
Manaf AlMatar et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Antisense antimicrobial therapeutics
Erin K. Sully et al.
CURRENT OPINION IN MICROBIOLOGY (2016)
The delivery of therapeutic oligonucleotides
Rudolph L. Juliano
NUCLEIC ACIDS RESEARCH (2016)
Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
Robert Penchovsky et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Totally drug-resistant tuberculosis and adjunct therapies
S. K. Parida et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Antibiotics present and future
S. Altman
FEBS LETTERS (2014)
Phosphoryl Guanidines: A New Type of Nucleic Acid Analogues
M. S. Kupryushkin et al.
ACTA NATURAE (2014)
Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections
Bo-Shiun Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Sensitive Detection of Gene Expression in Mycobacteria under Replicating and Non-Replicating Conditions Using Optimized Far-Red Reporters
Paul Carroll et al.
PLOS ONE (2010)
Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis
Vinita Chaturvedi et al.
JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY (2007)
Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis
Gunter Harth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Inhibition of mycobacterium smegmatis gene expression and growth using antisense peptide nucleic acids
A Kulyte et al.
JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY (2005)
Antisense technologies - Improvement through novel chemical modifications
J Kurreck
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis:: Proof of principle by using antisense technology
G Harth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Mycobacterium smegmatis L-alanine dehydrogenase (Ald) is required for proficient utilization of alanine as a sole nitrogen source and sustained anaerobic growth
ZY Feng et al.
JOURNAL OF BACTERIOLOGY (2002)
Bactericidal antisense effects of peptide-PNA conjugates
L Good et al.
NATURE BIOTECHNOLOGY (2001)
Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication
G Harth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
